Cardiac Systems
Medical Equipment ManufacturingMinnesota, United States2-10 Employees
The device that started the orbital atherectomy revolution returns with new technology, unparalleled clinical proof and a focus on conquering arterial calcium.
Strategic Acquisition Activity Recent acquisitions by leading players like Abbott and Neurosphere Virtual Clinic highlight a consolidating market with increased demand for advanced cardiovascular devices, presenting opportunities to position innovative atherectomy technology as a complementary solution for expanding market share.
Market Expansion Potential Cardiac Systems' focus on conquering arterial calcium and their recent technological advancements position them well to penetrate vascular and coronary treatment markets, particularly as healthcare providers seek minimally invasive and effective intervention options.
Technological Differentiation Their return with new technology backed by clinical proof offers a competitive advantage in delivering effective solutions for calcified artery treatment, creating sales prospects with hospitals and clinics upgrading their treatment tools.
Industry Partnerships Collaborations such as with Innova Vascular and acquisitions of assets like peripheral support catheters suggest a strategic focus on comprehensive vascular care, opening avenues for accessory and complementary device sales.
Growth Opportunities Despite a small revenue footprint, the company's innovative focus combined with larger players' acquisitions indicates significant growth potential in the medical device sector, appealing to investors and healthcare providers seeking cutting-edge treatment options.
Cardiac Systems uses 8 technology products and services including Google Ads Conversion Tracking, MySQL, Altium, and more. Explore Cardiac Systems's tech stack below.
| Cardiac Systems Email Formats | Percentage |
| FLast@csi360.com | 94% |
| First.Last@csi360.com | 5% |
| LFirst@csi360.com | 1% |
Medical Equipment ManufacturingMinnesota, United States2-10 Employees
The device that started the orbital atherectomy revolution returns with new technology, unparalleled clinical proof and a focus on conquering arterial calcium.
Cardiac Systems's revenue is estimated to be in the range of $1M
Cardiac Systems's revenue is estimated to be in the range of $1M